Having trouble viewing this email? View in your browser.
ESCMID Logo

5 December 2017
WEEKLY NEWS

Dear colleagues,

ESCMID’s emerging infection task force has published a new contribution about outbreaks of Candida auris in the United Kingdom and Spain.

Best regards, your ESCMID communications editors

 

Record number of abstracts submitted to ECCMID 2018

ESCMID thanks all the researchers who have submitted their work to our next congress. We have received more than 5,300 abstracts for ECCMID, which will take place from 21 – 24 April 2018 in Madrid. That is the highest number we have ever received. About 600 experts will start their review of the submissions from tomorrow. Submitters will be informed about acceptance by the end of January 2018.

› Read more
 

EUCIC launches European training in infection prevention and control

The two-year training programme starts in February 2018 with a basic and compulsory module in Groningen. Advanced modules follow in June and October of 2018, and in January, March, May and September of 2019. In addition, trainees will have the opportunity to attend local modules in different countries comprising the topics of the curriculum, follow e-learning modules, and apply for observerships. All medical doctors and pharmacists, nurses or other healthcare professionals with a MSc or PhD are eligible. After successful completion of the programme, trainees will receive the EUCIC Certificate in Infection Prevention and Control. Registration for the basic module is now open.

› Read more
 

Registration open for March 2018 arbovirus course in Bucharest

The goal of the course Preparing for (Re-)Emerging Arbovirus Infections in Europe is to improve the participant’s knowledge of identification and management of arbovirus (arthropod-borne virus) infections and outbreaks at local and European levels. The course from 21 – 23 March 2018 in Bucharest, Romania is part of the EU-PREPARE partnership, aimed at strengthening European preparedness for (re-)emerging infectious disease outbreaks. Course topics will include a review of arboviruses of importance to Europe, including endemic and travel-imported viruses. This will include an overview of symptomatology, diagnostics and interpretation of laboratory results and an update on prevention, vaccine and treatments for these viruses. The course will also include an overview of surveillance systems, European organizations, laboratories and clinical networks involved in surveillance, control and outbreak response and practical sessions covering serology interpretation, case scenarios and outbreak response exercises.

› Read more
 

One more week to cast your vote in the 2017 EC election!

The 2017 online election for the ESCMID Executive Committee (EC) is open until Tuesday, 12 December 2017 at 12:00 noon CET. ESCMID members may cast their votes for the election and determine who will represent their interests and area of practice at your society. You may choose one candidate representing clinical microbiology and two representing infectious diseases. Have a look at the profiles of the eight candidates who have offered their time and energy for ESCMID. Thank you for voting and selecting the future leadership of your society. We will announce the results both on the ESCMID website and in a special newsletter later in December.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.